Lilly shares slip after Bernie Sanders criticizes insulin prices
Makers of insulin became the latest target for Sen. Bernie Sanders, who has been going after pharmaceutical companies one by one over the issue of high U.S. drug prices.
Health Care & Insurance
Articles
Franciscan to build $50 million medical complex, micro-hospital in Johnson County
Franciscan Health said the complex at U.S. 135 and Stones Crossing Road will serve a rapidly growing part of Johnson County. It will be about 12 miles from its hospitals in Indianapolis and Mooresville.
TriMedx plans $21.5 million expansion, 108 jobs
TriMedx, a provider of health care technology management services, said it would invest the money in its 78,000-square-foot corporate headquarters near West 71st Street and Zionsville Road and elsewhere in the state.
UPDATE: Johnson Memorial plans $42M overhaul of Franklin campus
In the largest project in its history, Johnson Memorial plans to demolish its old hospital building and construct two new health care facilities.
Community Health outsources Indianapolis pharmacies to Walgreens
Community said having Walgreens run its pharmacies will give its patients access to more pharmacy locations with expanded hours. The hospital network also was impressed by Walgreens' technology that allows patients to interact with the pharmacy digitally.
Franciscan Alliance to demolish former Beech Grove hospital
The project, expected to take 18 months, will raze 900,000 square feet of adjoining buildings on a 15-acre site.
Health law consumers face least choice in program’s history
Americans in the health insurance markets created by President Barack Obama's law will have less choice next year than any time since the program started.
Drug firms fighting ‘tooth and nail’ against California ballot measure
Drugmakers including Eli Lilly and Co. are becoming increasingly vocal in fighting a California ballot proposition designed to bring down prices on prescription medicine.
Lilly sales, profit disappoint in final earnings report under Lechleiter
Sales of Lilly's Humalog insulin, its top-selling product, fell 9 percent, to $641 million, offsetting gains by a stable of new drugs that is helping the company weather a blitz of patent expirations.
Obama administration confirms double-digit premium hikes
Obamacare premiums will go up sharply next year under and many consumers will be down to just one insurer to choose from, the administration confirmed Monday.
IU’s new data science degree taps into hot health care market
The new degree blends such disciplines as biostatistics, computer science and informatics to better understand issues related to health care cost and quality.
Community Hospital North reopens 6 operating rooms
The hospital voluntarily closed the rooms Oct. 10 after finding discoloration on ceiling tiles and walls in a nearby corridor area.
Rules mandate some firms cover transgender services
Starting Jan. 1, any health care organization that takes federal money for health purposes can’t refuse to provide transgender services.
Lilly cancer drug lands accelerated FDA approval
Lartruvo is the first front-line therapy approved by the FDA to treat soft tissue sarcomas since doxorubicin more than 40 years ago.
Indy-based NICO works for acceptance of less invasive brain surgery tools
Currently, only about 2-4 percent of U.S. brain surgeries for tumors, strokes and other abnormalities are done with NICO’s low-invasive approach.
Purdue startup focuses on prostate cancer therapy
Research developed at Purdue University and licensed by a biomedical startup could give patients with late-stage prostate cancer an alternative to hormone therapies that can develop resistance after prolonged use.
Obama administration sets 13.8M goal for ACA sign-up season
This is shaping up to be the most difficult sign-up season since HealthCare.gov launched in 2013. Premiums are going up sharply in many parts of the country, and some major insurers have exited the program, leaving consumers with fewer choices.
Lilly pledges $90 million to improve global drug access
Eli Lilly and Co. is pledging $90 million over five years to improve access to treatment for diabetes, cancer and tuberculosis in developing countries—the latest push in its philanthropic strategy of building health care systems around the world and increasing the market for its prescription drugs.
Mainstreet accused of not paying nearly $2M in fees to adviser
A Chicago investment broker says the Carmel-based developer of transitional care properties is refusing to pay up for lining up a major investor in several projects.
Princeton to pay $18 million to settle residents’ tax case
The residents who sued sought to revoke the school’s property-tax exemption, in part because Princeton shares commercial royalties with faculty from a patent that Indianapolis-based Eli Lilly and Co. turned into the cancer drug Alimta.